Drugs Made In America Acquisition Corp
DMAAU10.400USD
-0.180-1.70%
交易中 （美东）报价延迟15分钟
0.00总市值
--市盈率 TTM
关于 Drugs Made In America Acquisition Corp 公司
Drugs Made In America Acquisition Corp. 是一家空白支票公司。该公司成立为豁免公司，旨在与一家或多家企业进行合并、股份交换、资产收购、股份购买、资本重组、重组或其他类似的业务合并。该公司寻找潜在目标企业的努力不会局限于特定行业或地理区域，尽管该公司打算专注于寻找制药行业的业务合并目标。
公司简介
公司代码DMAAU
公司名称Drugs Made In America Acquisition Corp
上市日期Jan 28, 2025
CEOMs. Lynn Stockwell
员工数量- -
证券类型Unit
年结日- -
公司地址1 East Broward Boulevard
城市FT LAUDERDALE
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编33301
电话19548703099
网址
公司代码DMAAU
上市日期Jan 28, 2025
CEOMs. Lynn Stockwell
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn C. Worman
Mr. Glenn C. Worman
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
名称
名称/职务
职务
持股
持股变动
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn C. Worman
Mr. Glenn C. Worman
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
Drugs Made In America Acquisition LLC
17.88%
Heights Capital Management, Inc.
2.77%
Boothbay Fund Management, LLC
2.58%
Westchester Capital Management, LLC
2.13%
RiverNorth Capital Management LLC
1.79%
Other
72.84%
持股股东
持股股东
占比
Drugs Made In America Acquisition LLC
17.88%
Heights Capital Management, Inc.
2.77%
Boothbay Fund Management, LLC
2.58%
Westchester Capital Management, LLC
2.13%
RiverNorth Capital Management LLC
1.79%
Other
72.84%
股东类型
持股股东
占比
Corporation
17.88%
Investment Advisor/Hedge Fund
7.68%
Hedge Fund
3.54%
Investment Advisor
2.85%
Research Firm
0.03%
Other
68.02%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
20
7.49M
31.98%
+7.31M
2025Q1
20
7.60M
32.43%
+7.41M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Drugs Made In America Acquisition LLC
4.19M
17.88%
+4.19M
--
Feb 18, 2025
Heights Capital Management, Inc.
650.00K
2.77%
+650.00K
--
Mar 31, 2025
Boothbay Fund Management, LLC
603.75K
2.58%
+603.75K
--
Mar 31, 2025
Westchester Capital Management, LLC
500.00K
2.13%
+500.00K
--
Mar 31, 2025
RiverNorth Capital Management LLC
420.50K
1.79%
+418.00K
+16719.92%
Mar 31, 2025
Context Capital Management LLC
250.00K
1.07%
+250.00K
--
Mar 31, 2025
Schonfeld Strategic Advisors LLC
234.83K
1%
+234.83K
--
Mar 31, 2025
Bulldog Investors, LLP
130.26K
0.56%
+130.26K
--
Mar 31, 2025
Wolverine Asset Management, LLC
130.00K
0.55%
+130.00K
--
Mar 31, 2025
Verition Fund Management LLC
100.00K
0.43%
+100.00K
--
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
SPAC and New Issue ETF
2.39%
RiverNorth Enhanced Pre-Merger SPAC ETF
0.51%
CrossingBridge Pre-Merger SPAC ETF
0%
SPAC and New Issue ETF
占比2.39%
RiverNorth Enhanced Pre-Merger SPAC ETF
占比0.51%
CrossingBridge Pre-Merger SPAC ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
